A phase 2/3 multicenter, randomized, placebo-controlled,

  • Shepela, Chris (PI)

Project: Research project

Project Details

Description

A phase 2/3 multicenter, randomized, placebo-controlled, double-blind study to evaluate the safety and efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects with Moderately to Severely Active Ulcerative Colitis
StatusFinished
Effective start/end date12/4/0712/31/14

Funding

  • Janssen Biotech, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.